Prosecution Insights
Last updated: August 06, 2026

The Broad Institute Inc.

9 pending office actions • 8 art units • 9 examiners • 0 of 9 (0%) have an AI response strategy ready • 9 patents granted in the last 365 days

Portfolio Summary

9
Total Pending OAs
5
Non-Final OAs
3
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
1
Due this week
1
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (2)Due ≤ 7 days (1)Due ≤ 30 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

5
Hard (56%)
2
Medium (22%)
2
Easy (22%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only1 (11%)
§101 + other2 (22%)
§103 only2 (22%)
§112 only2 (22%)
Multi-statute (no §101)2 (22%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

8
Life Sciences
89% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
11% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

90 h
Manual time on pending OAs
18 h
Time saved (low, 20%)
31 h
Time saved (mid, 35%)
0.8 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SAHAND, SANA 1 63.4% +24.5%
HALVORSON, MARK 1 48.1% +21.6%
PAGUIO FRISING, MICHELLE F 1 70.8% +40.5%
KOVACH, KARA NICOLE 1 85.7% +100.0%
POPA, ILEANA 1 21.5% +14.6%
BUNKER, AMY M 1 29.1% +45.3%
LAFAVE, ELIZABETH ROSE 1 59.6% +45.2%
BAUSCH, SARAE L 1 29.6% +44.4%
BEHARRY, ZANNA MARIA 1 23.2% +52.7%

Hard Cases (6)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
17906115 METHODS AND COMPOSITIONS FOR IDENTIFYING AND TREATING GLUTAMINASE INHIBITOR-SENSITIVE CANCERS BAUSCH, SARAE L 118d overdue
19197587 METHOD AND DEVICE TO PREDICT EXERCISE PEAK VO2, CARDIOVASCULAR OUTCOMES AND FUTURE DEATH USING ECG DEEP LEARNING MODELS SAHAND, SANA 32d overdue
18446945 COMPOSITIONS FOR DETECTING SECRETION AND METHODS OF USE POPA, ILEANA 26d
18580579 COMPOSITIONS AND METHODS FOR CHARACTERIZING A COMPLEX BIOLOGICAL SAMPLE KOVACH, KARA NICOLE
18266555 METHODS FOR DUPLEX REPAIR BUNKER, AMY M
17615579 REPRODUCIBLE BRAIN ORGANOIDS AND METHODS OF MAKING BEHARRY, ZANNA MARIA

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17906115 METHODS AND COMPOSITIONS FOR IDENTIFYING AND TREATING GLUTAMINASE INHIBITOR-SENSITIVE CANCERS BAUSCH, SARAE L 118d overdue
19197587 METHOD AND DEVICE TO PREDICT EXERCISE PEAK VO2, CARDIOVASCULAR OUTCOMES AND FUTURE DEATH USING ECG DEEP LEARNING MODELS SAHAND, SANA 32d overdue
19074044 FORMULATIONS FOR NEOPLASIA VACCINES HALVORSON, MARK 5d
18446945 COMPOSITIONS FOR DETECTING SECRETION AND METHODS OF USE POPA, ILEANA 26d
18690382 SUBSTRATES AND BIOMARKERS OF ADAMTS7 PAGUIO FRISING, MICHELLE F
18580579 COMPOSITIONS AND METHODS FOR CHARACTERIZING A COMPLEX BIOLOGICAL SAMPLE KOVACH, KARA NICOLE
18266555 METHODS FOR DUPLEX REPAIR BUNKER, AMY M
17927112 NUCLEIC ACID ARTIFICIAL MINI-PROTEOME LIBRARIES LAFAVE, ELIZABETH ROSE

Top Art Units

Art UnitApps
1684 2
3796 1
1646 1
1651 1
1681 1
1633 1
1699 1
1632 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19197587 METHOD AND DEVICE TO PREDICT EXERCISE PEAK VO2, CARDIOVASCULAR OUTCOMES AND FUTURE DEATH USING ECG DEEP LEARNING MODELS SAHAND, SANA 3796 §101 Non-Final OA 32d overdue Pending May 02, 2025
19074044 FORMULATIONS FOR NEOPLASIA VACCINES HALVORSON, MARK 1646 §112 Final Rejection 5d Pending Mar 07, 2025
18690382 SUBSTRATES AND BIOMARKERS OF ADAMTS7 PAGUIO FRISING, MICHELLE F 1651 §112 Non-Final OA Pending Mar 08, 2024
18580579 COMPOSITIONS AND METHODS FOR CHARACTERIZING A COMPLEX BIOLOGICAL SAMPLE KOVACH, KARA NICOLE 1681 §101§103§112 Non-Final OA Pending Jan 18, 2024
18446945 COMPOSITIONS FOR DETECTING SECRETION AND METHODS OF USE POPA, ILEANA 1633 §103 Final Rejection 26d Pending Aug 09, 2023
18266555 METHODS FOR DUPLEX REPAIR BUNKER, AMY M 1684 §102§103§112 Non-Final OA Pending Jun 09, 2023
17927112 NUCLEIC ACID ARTIFICIAL MINI-PROTEOME LIBRARIES LAFAVE, ELIZABETH ROSE 1684 §103 Non-Final OA Pending Nov 22, 2022
17906115 METHODS AND COMPOSITIONS FOR IDENTIFYING AND TREATING GLUTAMINASE INHIBITOR-SENSITIVE CANCERS BAUSCH, SARAE L 1699 §101§102§112 Non-Final OA 118d overdue Pending Sep 12, 2022
17615579 REPRODUCIBLE BRAIN ORGANOIDS AND METHODS OF MAKING BEHARRY, ZANNA MARIA 1632 §103§112 Final Rejection Pending Nov 30, 2021

Managing The Broad Institute Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month